249420 — Il Dong Pharmaceutical Co Cashflow Statement
0.000.00%
- KR₩386bn
- KR₩535bn
- KR₩601bn
Annual cashflow statement for Il Dong Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -13,444 | -13,019 | -100,968 | -142,170 | -80,961 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 38,251 | 32,629 | 64,410 | 80,230 | 37,128 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11,361 | -27,907 | -4,118 | -21,146 | -21,101 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 41,366 | 19,366 | -11,366 | -53,541 | -36,615 |
Capital Expenditures | -19,353 | -19,205 | -19,790 | -19,605 | -18,188 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 5,327 | 802 | -23,578 | -6,830 | -2,172 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -14,026 | -18,403 | -43,368 | -26,435 | -20,360 |
Financing Cash Flow Items | — | — | 7,639 | -49.3 | -70.4 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -13,484 | -4,576 | 104,316 | -3,287 | 58,152 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 14,022 | -4,395 | 50,022 | -83,440 | 1,112 |